Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Critical Reviews in Oncology/Hematology
|
March 16, 2010
Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma
Hans Wildiers, Marcel Reiser
Idrugs : the Investigational Drugs Journal
|
June 6, 2003
Pixantrone (Novuspharma)
Peter Borchmann, Marcel Reiser
Onkologie
|
March 4, 2006
Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab
Markus Jensen, Thomas Elter, Andreas Engert, et al.
Leukemia & Lymphoma
|
December 15, 2005
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study
Susanne Rödel, Andreas Engert, Volker Diehl, et al.
British Journal of Haematology
|
July 25, 2003
Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review
Julia Bohlius, Marcel Reiser, Guido Schwarzer, et al.
Seminars in Hematology
|
October 10, 2006
Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas
Gerhard Held, Joerg Schubert, Marcel Reiser, et al.
The Cochrane Database of Systematic Reviews
|
January 20, 2012
High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults
Markus Schaaf, Marcel Reiser, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews
|
October 10, 2008
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
Julia Bohlius, Christine Herbst, Marcel Reiser, et al.
Haematologica
|
July 20, 2004
Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma
Achim Rothe, Holger Schulz, Thomas Elter, et al.
Onkologie
|
September 15, 2005
Implementation and evaluation of a central coordination office for clinical trials in a tertiary care hospital
Sven Trelle, Jan Oliver Staak, Markus Jensen, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Critical Reviews in Oncology/Hematology
|
March 16, 2010
Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma
Hans Wildiers, Marcel Reiser
Idrugs : the Investigational Drugs Journal
|
June 6, 2003
Pixantrone (Novuspharma)
Peter Borchmann, Marcel Reiser
Onkologie
|
March 4, 2006
Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab
Markus Jensen, Thomas Elter, Andreas Engert, et al.
Leukemia & Lymphoma
|
December 15, 2005
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study
Susanne Rödel, Andreas Engert, Volker Diehl, et al.
British Journal of Haematology
|
July 25, 2003
Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review
Julia Bohlius, Marcel Reiser, Guido Schwarzer, et al.
Seminars in Hematology
|
October 10, 2006
Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas
Gerhard Held, Joerg Schubert, Marcel Reiser, et al.
The Cochrane Database of Systematic Reviews
|
January 20, 2012
High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults
Markus Schaaf, Marcel Reiser, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews
|
October 10, 2008
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
Julia Bohlius, Christine Herbst, Marcel Reiser, et al.
Haematologica
|
July 20, 2004
Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma
Achim Rothe, Holger Schulz, Thomas Elter, et al.
Onkologie
|
September 15, 2005
Implementation and evaluation of a central coordination office for clinical trials in a tertiary care hospital
Sven Trelle, Jan Oliver Staak, Markus Jensen, et al.
Page
of 8